Ezh2 inhibition resulted in increased frequency of IFN-γ producing tumor-infiltrating CD8+ T cells (135), whereas Ezh2-deficient CD8+ T cells exhibit an impaired ability to produce IFN-γ in a virus infection model (136). Here, CD8A is linked to neoplasm.